Poplar Therapeutics Closes $45 million Series A Extension to Advance Development of Lead Program, PHB-050, A New Class of Anti-IgE Therapy for Multiple Atopic Conditions Extension financing adds new investors, Janus Henderson Investors and RA Capital, with strong renewed participation…
Acadia Pharmaceuticals Reports Strong Fourth Quarter and Record Full-Year 2025 Financial Results, Highlights Pipeline Progress and Strategic Expansion Acadia Pharmaceuticals Inc today announced its financial results for the fourth quarter and full-year ended December 31, 2025, marking a milestone year…
BioTalent Canada Breaks Barriers in Opening Applications for 2026 I.D.E.A.L. Scholarship™ BioTalent Canada has opened applications for the third annual I.D.E.A.L. Scholarship which will close on June 8, 2026. Full details and application forms available on BioTalent Canada’s website.Breaking down financial…
Sarepta Therapeutics Reports Strong Financial Performance and Advances in Gene and RNA Therapies for Rare Diseases in 2025 Sarepta Therapeutics, Inc., a recognized leader in precision genetic medicine for rare diseases, today reported its financial results for the fourth quarter…
Sun Nuclear Introduces Daily QA 4 Pro to Enhance Machine Quality Assurance in Cancer Care Why is the future of cancer care quality and patient safety becoming increasingly critical for medical physicists and radiation therapy professionals? Sun Nuclear, a Mirion…
Montrose Environmental Group Reports Record 2025 Performance and Strong Outlook for 2026 Montrose Environmental Group, Inc., a leading provider of environmental services committed to protecting air, water, and soil while promoting sustainable economic growth, today announced its financial results for…
New Combination Therapy Demonstrates 47% Reduction in Event-Free Survival Events Why is this a game-changer for bladder cancer treatment? Merck, a global leader in healthcare, has announced groundbreaking results from the Phase 3 KEYNOTE-B15 trial, which demonstrated that the combination of…
Corning Launches Gorilla Glass Ceramic 3: Redefining Durability for Modern Smartphones Corning Incorporated , a global leader in specialty glass and materials science, has unveiled its latest innovation in protective cover glass technology: Corning® Gorilla® Glass Ceramic 3. Billed as…
Sarepta Supports Educational Ambitions of Duchenne Community with $5,000 Scholarships Why is supporting the education of individuals with Duchenne muscular dystrophy crucial for the future of rare disease treatment? Sarepta Therapeutics, a leader in precision genetic medicine for rare diseases,…
Wyss Geneva Spin-Off Clee Medical Secures Seed Financing to Bring Real-Time Vision to Brain Surgery The Wyss Center for Bio and Neuroengineering Geneva announced today the successful closing of the Seed financing round of Clee Medical SA, a Swiss neurotechnology spin-off developing…